To explore the functional consequences of SLC7A11 inhibition, we employed diverse techniques including qPCR, Western blotting, and IF to confirm successful knockdown of SLC7A11 in NSCLC cell lines NCI‐H2122 and NCI‐H647. Here, SLC7A11 is linked to non-small cell lung carcinoma.